Skip to main content

Table 2 Population characteristics

From: Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial

  

Overall

Arm A

(active LLLT/PBMT)

(N = 42)

ArmB

(placebo LLLT/PBMT)

(N = 41)

p-value

Gender

Female

8 (9.6%)

5 (11.9%)

3 (7.3%)

0.74

 

Male

75 (90.4%)

37 (88.1%)

38 (92.7%)

 

Age (years)

Mean ± SD

58 (53–65)

58 (53–62)

58 (53–68)

0.25

Tumour Location

Oral cavity

17 (20.5%)

9 (21.4%)

8 (19.5%)

0.70

 

Hypopharynx

19 (22.9%)

11 (26.2%)

8 (19.5%)

 

Oropharynx

47 (56.6%)

22 (52.4%)

25 (61.0%)

 

TNM classification

T1

7

3 (7.1%)

4 (9.8%)

0.09

 

T2

24

16 (38.1%)

8 (19.5%)

 

T3

34

16 (38.1%)

18 (43.9%)

 

T4a

13

7 (16.7%)

6 (14.6%)

 

T4b

5

0 (0%)

5 (12.2%)

 

N0

15

5 (11.9%)

10 (24.4%)

0.36

N1

6

2 (4.8%)

4 (9.8%)

 

N2

56

31 (73.8%)

25 (61.0%)

 

N3

5

3 (7.1%)

2 (4.9%)

 

Nx

1

1 (2.4%)

0 (0%)

 

M0

83 (100%)

42 (100%)

41 (100%)

 

Histologic differentiation

Well-differentiated

36 (43.4%)

17 (40.5%)

19 (46.3%)

0.25

 

Unknown

6 (7.2%)

4 (9.5%)

2 (4.9%)

 

Moderately differentiated

31 (37.3%)

18 (42.9%)

13 (31.7%)

 

Poorly differentiated

10 (12.0%)

3 (7.1%)

7 (17.1%)

 

Smoking status

Never-smokers

12 (14.5%)

3 (7.1%)

9 (22%)

0.11

 

Smokers

71 (85.5%)

39 (92.9%)

32 (78%)

 

During CRT

Smoking cessation

8 (11.3%)

4 (10.3%)

4 (12.5%)

0.95

 

Active smokers

23 (32.4%)

13 (33.3%)

10 (31.3%)

 

Unspecified

40 (56.3%)

22 (56.4%)

18 (56.3%)

 

Alcohol consumption

No

22 (26.5%)

11 (26.2%)

11 (26.8%)

0.92

 

Unknown

3 (3.6%)

1 (2.4%)

2 (4.9%)

 

Yes

58 (69.9%)

30 (71.4%)

28 (68.3%)

 

During CRT

Alcohol withdrawal

8 (13.8%)

3 (10.0%)

5 (17.9%)

0.72

 

Active alcohol use

21 (36.2%)

11 (36.7%)

10 (35.7%)

 

Unspecified

29 (50.0%)

16 (53.3%)

13 (46.4%)

 

Feeding

Enteral feeding

9 (10.8%)

3 (7.1%)

6 (14.6%)

0.39

 

Liquid diet

1 (1.2%)

1 (2.4%)

0 (0%)

(0.64 with binary data)

Minced food

23 (27.7%)

13 (31%)

10 (24.4%)

Unspecified

2 (2.4%)

0 (0%)

2 (4.9%)

Solid diet

48 (57.8%)

25 (59.5%)

23 (56.1%)

 
  1. TNM Tumour/Node/Metastasis.
  2. CRT Chemoradiotherapy.